Understanding what makes key opinion leaders prefer one company’s
programs over another company’s can give you a considerable edge as you
design a marketing plan that includes valuable insight from these highly
influential physicians.
PharmaForce has polled hundreds of KOLs in the United States. This
report is your opportunity to find out what KOLs across key therapeutic
areas have told us about the following:
–
What companies run the best advisory boards and why
–
Acceptable honorarium levels
–
Factors KOLs consider when deciding whether or not to
attend a program
–
Preferred meeting focus and structure
–
Topics of key interest
–
Differences in perspectives of researchers vs. clinicians
For clients
interested in this same type of information on a global scale, a similar
study is available on KOL perspectives in Europe.
* Save 5% -- Mention "PharmCast.com" when
purchase.
To receive more information about the study,
please click on the
following "Request for Info" link.